EDHARRINGTON's journey to regrow his hair using finasteride, topical minoxidil, and micro-needling treatments over 4 years, with others commenting their support and admiration for his results.
The user experienced increased hair stubble after using 1mg finasteride, 3mg minoxidil, microneedling twice weekly, and daily biotin and vitamin D. They plan to grow their hair out to assess coverage.
Using a combination of micro-needling and exosome injections as a potential treatment for male pattern baldness, which could result in 50% or more regrowth.
User doing PRP with exosomes for hair loss, sees possible regrowth after two treatments. Another user suggests providing before and after pictures for better assessment.
The user has been treating hair loss for 7 months using a combination of pyrilutamide, a topical mix of finasteride and minoxidil, microneedling, a topical mix of GHK-Cu and minoxidil, ketoconazole shampoo, fish collagen peptides, zinc, and vitamin D3. Another user suggests that continuous small improvements could lead to significant hair regrowth over time.
Treatment options for hair regrowth other than minoxidil or finasteride, due to side effects from the latter, with platelet-rich plasma and topical treatments being among the suggested alternatives.
GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.
A user shared their 8-month progress using oral dutasteride and 2.5 mg oral minoxidil daily, reporting improved hair density with minimal side effects, except for a slightly decreased libido. They did not use any supplements but occasionally used a derma stamp.
A 28-year-old male using Tugain 10 minoxidil, Finpecia 1mg finasteride, Cipla Ketoconazole shampoo, and dermarolling 0.5mm weekly for 3-4 months is seeing some hair regrowth. Encouragement is given to continue the regimen.
GT-20029 is discussed as a potential hair loss treatment, with concerns about its safety and systemic absorption compared to finasteride. Users express skepticism about its effectiveness and safety, noting that it may not surpass existing treatments like finasteride and minoxidil.
User started balding at 16 and began treatment at 18, using RU58841, minoxidil, derma rolling, and peptides. After 6 months, they experienced significant hair regrowth and are happy with the results.
The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.
A 29-year-old male experienced significant hair regrowth over 8 months using a protocol of oral Minoxidil, Dutasteride, Pyrithione Zinc Shampoo, and peptides GHK-CU, BPC-157, and TB-500. The treatment led to improved scalp coverage, reduced hair loss, and thicker hair, although results may vary for others.
The user experienced hair regrowth using finasteride, biotin, folic acid, vitamin D3, and microneedling, despite initial shedding. Vitamin D3 deficiency caused hair loss and insomnia.
The user experienced hair regrowth using daily oral finasteride and topical minoxidil applied about five times a week, with some existing hair becoming thicker and new growth appearing. They also used dermastamping once a month and are considering adding topical GHK-Cu to their regimen.
A user shared their positive experience 12 months after a hair transplant with 4052 grafts and 10130 hairs, using finasteride, red light therapy, B12, biotin, and rosemary oil. They are satisfied with the results and recommend these treatments.
Dr. Bloxham's trial is testing verteporfin on hair transplant patients to see if it can improve hair regrowth in treated areas. People are discussing the potential for follicle regeneration, expected results timeline, and concerns about side effects like cancer.
A user reports hair regrowth at the temples after starting 0.33g of finasteride every other day in January, combined with weekly microneedling sessions. They experienced sexual side effects at higher doses, which improved with a lower dose and supplements like broccoli extract and l-citrulline.
A user, 35M, has been using oral finasteride for 5 years and 5% minoxidil for 3 years, which stopped hair loss but didn't promote regrowth. After starting RU58841 5 months ago, they noticed long, translucent hairs and are asking if these hairs will darken and how to encourage this.
The user experienced significant hair regrowth using topical finasteride for 8-9 months, topical minoxidil for 3 months, and weekly microneedling with a stamp. They reported no side effects from the topical treatments and are considering a hair transplant for further improvement.
A user on finasteride for 8 months shared bloodwork results showing increased testosterone and estradiol levels, with concerns about high LH. Responses advised monitoring for symptoms but noted levels are within reference ranges.
The user reports potential hair regrowth after using finasteride nightly, minoxidil twice daily, occasional microneedling, and vitamin supplements, and is considering RU58841 in the future. Replies suggest they are seeing improvement.
The conversation is about testing the effectiveness of RU58841 for hair loss, with the user planning to increase their dose to 30 mg per day along with 20 mg of Minoxidil. The test results showed approximately 70 mg/ml, which the user considers a good result.
The user has been using oral finasteride and minoxidil, along with biotin, vitamin D3, collagen, and micro-needling, to address hair loss over six months. They experienced some shedding initially but have seen progress, with improved hair quality and reduced bald spots.
The conversation discusses hair loss treatments, mentioning minoxidil, finasteride, RU58841, VDPHL, GT20029, and follicle cloning as potential solutions. It also reveals that the discussion about PP405 was an April Fool's joke.
The user is pleased with their hair transplant results but is concerned about the vertex area. They use Minoxidil and finasteride daily and had the procedure at a clinic in Athens.
The conversation is about when GT20029, a hair loss treatment, might be available on the grey market, with users discussing the challenges of compounding it and speculating it might be available after phase 2 results, similar to pyri. Specific treatments mentioned are pyri, RU58841, and GT20029.